17-81035353-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001144888.2(BAIAP2):c.54+45T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.903 in 1,231,708 control chromosomes in the GnomAD database, including 502,910 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.88 ( 57981 hom., cov: 31)
Exomes 𝑓: 0.91 ( 444929 hom. )
Consequence
BAIAP2
NM_001144888.2 intron
NM_001144888.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.53
Genes affected
BAIAP2 (HGNC:947): (BAR/IMD domain containing adaptor protein 2) The protein encoded by this gene has been identified as a brain-specific angiogenesis inhibitor (BAI1)-binding protein. This adaptor protein links membrane bound G-proteins to cytoplasmic effector proteins. This protein functions as an insulin receptor tyrosine kinase substrate and suggests a role for insulin in the central nervous system. It also associates with a downstream effector of Rho small G proteins, which is associated with the formation of stress fibers and cytokinesis. This protein is involved in lamellipodia and filopodia formation in motile cells and may affect neuronal growth-cone guidance. This protein has also been identified as interacting with the dentatorubral-pallidoluysian atrophy gene, which is associated with an autosomal dominant neurodegenerative disease. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.913 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BAIAP2 | NM_001144888.2 | c.54+45T>C | intron_variant | ENST00000428708.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BAIAP2 | ENST00000428708.7 | c.54+45T>C | intron_variant | 1 | NM_001144888.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.884 AC: 130896AN: 148152Hom.: 57949 Cov.: 31
GnomAD3 genomes
AF:
AC:
130896
AN:
148152
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.901 AC: 54029AN: 59956Hom.: 24368 AF XY: 0.903 AC XY: 32057AN XY: 35488
GnomAD3 exomes
AF:
AC:
54029
AN:
59956
Hom.:
AF XY:
AC XY:
32057
AN XY:
35488
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.906 AC: 981505AN: 1083448Hom.: 444929 Cov.: 21 AF XY: 0.906 AC XY: 479152AN XY: 528830
GnomAD4 exome
AF:
AC:
981505
AN:
1083448
Hom.:
Cov.:
21
AF XY:
AC XY:
479152
AN XY:
528830
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.883 AC: 130977AN: 148260Hom.: 57981 Cov.: 31 AF XY: 0.885 AC XY: 63984AN XY: 72262
GnomAD4 genome
AF:
AC:
130977
AN:
148260
Hom.:
Cov.:
31
AF XY:
AC XY:
63984
AN XY:
72262
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3054
AN:
3296
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Attention deficit hyperactivity disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Gene Variants in BAIAP2 have been studied in several populations and are known to cause ADHD. Potent variants of this gene prevent neuronal growth, maturation and survival, essential for proper functioning of frontal cortical and subcortical circuits. However, more clinical evidence is required to confer the association of this particular variant rs8073224 with Attention-deficit hyperactivity disorder. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at